Phase 3 Metabolic Disease Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Nervous system diseasePeripheral nervous system diseaseAmyloidosis+17 more
Intellia Therapeutics60 enrolled14 locationsNCT06672237
Recruiting
Phase 2Phase 3
A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II
Metabolic DiseasesMucopolysaccharidosis Type II
AO GENERIUM32 enrolled5 locationsNCT05208281
Recruiting
Phase 3
A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
Primary hypercholesterolemiaMetabolic DiseaseDyslipidemias+4 more
Hasten Biopharmaceutical Co., Ltd.210 enrolled18 locationsNCT06568471